ARGX (argenx N.V.) Gross Sales Margin

Corporate emblem and logo of argenx BVBA (ARGX)

argenx SE relies on the sales of a single immune drug, expanding its application across various diseases. Historical gross margin reflects profitability trends, where the value of 89.50 corresponds to the current metric. Growth potential is driven by unique antibodies and the blockbuster Vyvgart. Business flexibility is maintained by fully outsourcing production and testing to external partners.

Gross Profitability: argenx N.V. (ARGX) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for argenx SE (ARGX)

- stock price and consensus target price:
- business market valuation indicators:
Basic company analysis:ARGX - argenx
Brand item of argenx BVBA

argenx SE dominates the autoimmune disease therapy segment thanks to its high-profit drug Vyvgart. Gross margin measures the share of profit after deducting direct production costs, reflecting the efficiency of cost-of-sales management. For the investor, this ratio serves as an indicator of the company's pricing power and the stability of its cash flows. An analysis of production margins confirms the business's ability to monetize unique medical demand without increasing operating expenses.

Direct competitors

BNTX - Return on Sales by Gross Profit|ABVX (Abivax Pharma) - Gross Margin|Return on Gross Profit ADMA Bio (ADMA)|Return on Gross Profit PTGX (Protagonist Therapeutics Inc)|Gross Margin immunovant.com (IMVT)|Gross Profitability kiniksa.com KNSA|Grifols SA (GRFS) - Gross Profit Margin|Adaptive Biotechnologies Inc. - Gross Margin|Gross Profit Margin Celldex Therapeutics|AUPH: Gross Margin|BCRX - Return on Sales by Gross Profit|VERA (Vera Corp) - Gross Margin|Dianthus Pharma (DNTH) - Return on Sales by Gross Profit|Gross Profitability Pharvaris Pharma (PHVS)|Gross Margin AbCellera Corp (ABCL)|Gross Margin TRML (Tourmaline Bio Inc)|Return on Sales by Gross Profit precigen.com (PGEN)|PHAR - Gross Profitability|Gross Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Gross Profit|Zenas Corp (ZBIO) - Gross Margin|Return on Gross Profit IMNM|GOSS: Gross Profit Rate|Gross Profitability KalVista Pharma (KALV)|SEPN - Gross Profit Margin|Gross Margin PVLA (pieris.com)|Gross Margin Savara Pharma SVRA|RIGL: Return on Gross Profit|ANAB - Gross Margin|ATXS: Gross Margin|ENGN - Return on Sales by Gross Profit|Return on Gross Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Gross Profit Ratio|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability